Grifols SA (GRFS)

NASDAQ:GRFS

GRFS

Grifols SA

RESEARCH TOOLSreports

Compare Grifols SA (GRFS) vs. Competitors

468 Followers

Comparison Results

GRFS

Grifols SA

$8.78

$6.38B

14.03

18.53%

―

Amgen

$351.85

$189.67B

22.84

15.10%

12 Buy

11 Hold

1 Sell

Moderate Buy

Bristol-Myers Squibb

$60.65

$123.51B

15.61

3.66%

8 Buy

11 Hold

1 Sell

Moderate Buy

Gilead Sciences

$139.37

$173.02B

17.94

26.08%

16 Buy

5 Hold

0 Sell

Strong Buy

GlaxoSmithKline

$55.19

$109.21B

28.75

47.85%

1 Buy

3 Hold

1 Sell

Hold

Sanofi

$48.18

$115.15B

-31.42

-12.16%

1 Buy

2 Hold

0 Sell

Moderate Buy

xxxxxxxxxxxxx

GRFS vs SNY

xxxxxxxxxxxxx

Performance Comparison

GRFS

Grifols SA

8.25

1.23

17.52%

AMGN

Amgen

353.28

52.86

17.59%

BMY

Bristol-Myers Squibb

61.73

6.69

12.16%

GILD

Gilead Sciences

140.30

30.82

28.15%

GSK

GlaxoSmithKline

55.99

18.47

49.24%

SNY

Sanofi

47.73

-5.20

-9.83%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >